deutraMed™ is attending the 2024 Electronic Specialty Gas & Systems (ESGS) Conference at Wild Horse Pass in Chandler, Arizona. Steven Bovair, Sales Manager, will represent the company at the annual event, which takes place October 22-24, 2024.
deutraMed is a leading global supplier of deuterium (D2) gas, which is used globally in the fabrication of semiconductors and fibre optics. We work directly with customers who are actively seeking to recover deuterium from end-use applications for re-enrichment and reuse. deutraMed’s re-enrichment process significantly reduces the need to rely on new supplies of deuterium oxide, the raw material used to produce the deuterium gas that is used in semiconductor manufacturing.
Most deuterium oxide available in the market today is produced with energy-intensive processes that depend heavily on electricity from coal-fired power plants. The recovery and re-enrichment of deuterium gas would provide a significant sustainability benefit by capturing gas with a Global Warming Potential (GWP) up to 15 times that of CO2 – a GWP that is equivalent to methane. Further, it can react with and amplify the GWP of fluoro-compounds with a GWP thousands of times higher than CO2. It is therefore important to continue R&D around the capture, recovery and reuse of D2 gas.
The ESGS conference focuses on the market, technology trends and market drivers for electronic gases. This includes developments in the bulk, rare and specialty gas markets that are critical to the continued growth of the electronics industry. The conference, a gathering place for executives, buyers, product managers, and strategic planners from the electronic gases value chain, features industry experts with insights on key developments and challenges in this market.
To connect with Steven Bovair, please send an email to sales@deutramed.com.
More information about the conference can be found here.
